Sponsors and Partners
MEET OUR PARTNERS AND SPONSORS
The FH Foundation is one of the leading organizations fighting all forms of familial hypercholesterolemia (FH) at every stage and on all fronts. We are fortunate to have such dedicated and caring companies supporting our organization, and we thank them on behalf of the millions who have been affected by FH.
We strive to develop strategic partnerships with companies who share our values and vision – preventing cardiovascular disease by improving diagnosis and treatment of FH while enhancing the scientific understanding of this disorder in order to dramatically improve patients’ lives. We invite you to be a part of the various sponsorship opportunities The FH Foundation has to offer throughout the year. Sponsorship is a tremendous opportunity to showcase your commitment to the FH Community. Thank you.
FH Foundation Corporate Sponsors
Our Corporate Advisory Council is supporting the FH Foundation in its efforts to raise awareness and save lives of those with FH. Their contributions help fund programs, which encourage and advocate for increased knowledge of FH, earlier diagnosis, optimum treatment, and enhanced scientific understanding of this disease.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme.
Regeneron (NASDAQ: REGN) is a leading science and technology company delivering new medicines for people with serious medical conditions. Led by physician-scientists for over 25 years, our science-driven approach has resulted in four FDA-approved treatments and numerous homegrown product candidates in diseases including cancer, rheumatoid arthritis, asthma, atopic dermatitis, pain and infectious diseases. In addition to our medicines, our innovations include two of the most valuable biotechnology platforms ever invented, one of the largest human sequencing efforts in the world, and rapid response technologies being applied for global good.
23andMe is named after the 23 pairs of chromosomes in your DNA. We are a web-based service that helps you understand what your DNA says about your health, traits and ancestry. After providing a saliva sample using an at-home kit, you can learn how your genetics may influence your health, discover where your DNA is from out of 31 populations worldwide - and more. Learn what makes you uniquely you with 23andMe!
MTS Health Partners, L.P. is the preeminent financial services firm dedicated solely to the healthcare industry. We operate two independent businesses, investment banking and private equity, each led by a dedicated team of professionals. As a privately owned and managed business, we can ensure that the interests of our clients and investment partners always come first.